Joung Eun Lim

748 total citations
20 papers, 577 citations indexed

About

Joung Eun Lim is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Joung Eun Lim has authored 20 papers receiving a total of 577 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Pulmonary and Respiratory Medicine and 6 papers in Surgery. Recurrent topics in Joung Eun Lim's work include Prostate Cancer Treatment and Research (5 papers), Bladder and Urothelial Cancer Treatments (4 papers) and Epigenetics and DNA Methylation (3 papers). Joung Eun Lim is often cited by papers focused on Prostate Cancer Treatment and Research (5 papers), Bladder and Urothelial Cancer Treatments (4 papers) and Epigenetics and DNA Methylation (3 papers). Joung Eun Lim collaborates with scholars based in South Korea, Canada and Armenia. Joung Eun Lim's co-authors include Byong Chang Jeong, Han Yong Choi, Seong Soo Jeon, Hye Won Lee, Seong Il Seo, Do‐Hyun Nam, Kyeung Min Joo, Da Eun Jeong, Hyun Moo Lee and Ghee Young Kwon and has published in prestigious journals such as SHILAP Revista de lepidopterología, Oncogene and Scientific Reports.

In The Last Decade

Joung Eun Lim

19 papers receiving 569 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joung Eun Lim South Korea 12 314 143 138 132 124 20 577
Chengzhi Huang China 13 218 0.7× 128 0.9× 74 0.5× 97 0.7× 144 1.2× 38 475
Tao Tan China 13 232 0.7× 176 1.2× 74 0.5× 89 0.7× 65 0.5× 37 645
Guanghai Dai China 15 265 0.8× 281 2.0× 75 0.5× 121 0.9× 223 1.8× 61 663
Yu Wen China 9 168 0.5× 175 1.2× 123 0.9× 112 0.8× 98 0.8× 17 622
Quanli Han China 13 192 0.6× 175 1.2× 47 0.3× 90 0.7× 130 1.0× 33 411
Chang Yang China 13 498 1.6× 250 1.7× 91 0.7× 115 0.9× 339 2.7× 37 953
Xuefeng Liu China 11 265 0.8× 115 0.8× 55 0.4× 127 1.0× 195 1.6× 21 528
Zhenfeng Guan China 14 358 1.1× 185 1.3× 111 0.8× 121 0.9× 167 1.3× 25 643
Niki A. Ottenhof United States 12 456 1.5× 531 3.7× 116 0.8× 114 0.9× 165 1.3× 13 882
Hao Peng China 12 117 0.4× 251 1.8× 101 0.7× 136 1.0× 98 0.8× 31 537

Countries citing papers authored by Joung Eun Lim

Since Specialization
Citations

This map shows the geographic impact of Joung Eun Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joung Eun Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joung Eun Lim more than expected).

Fields of papers citing papers by Joung Eun Lim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joung Eun Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joung Eun Lim. The network helps show where Joung Eun Lim may publish in the future.

Co-authorship network of co-authors of Joung Eun Lim

This figure shows the co-authorship network connecting the top 25 collaborators of Joung Eun Lim. A scholar is included among the top collaborators of Joung Eun Lim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joung Eun Lim. Joung Eun Lim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lim, Joung Eun, et al.. (2025). HSF1–DBC1 axis drives prostate cancer progression by activating a metastatic transcriptional program. Experimental & Molecular Medicine. 57(10). 2277–2291.
2.
Lim, Joung Eun, et al.. (2024). Therapeutic Potential of Bipolar Androgen Therapy for Castration-Resistant Prostate Cancer: In Vitro and In Vivo Studies. Biomedicines. 12(1). 181–181. 1 indexed citations
3.
Lim, Joung Eun, Minji Park, Mijeong Lee, et al.. (2024). Evaluating a combination treatment of NK cells and reovirus against bladder cancer cells using an in vitro assay to simulate intravesical therapy. Scientific Reports. 14(1). 7390–7390. 1 indexed citations
4.
Lim, Joung Eun, Minji Park, Mijeong Lee, et al.. (2023). 897-D Combinational treatment of reovirus and NK cells against bladder cancer cells using an intravesical therapy mimicking in vitro assay. SHILAP Revista de lepidopterología. A1822–A1822. 1 indexed citations
5.
Cho, Eun‐Hae, Joung Eun Lim, Jae Hoon Chung, et al.. (2022). Chromosomal Instability in Cell-free DNA as a Prognostic Biomarker of Metastatic Hormone-sensitive Prostate Cancer Treated with Androgen Deprivation Therapy. European Urology Focus. 9(1). 89–95. 2 indexed citations
6.
Cho, Eun‐Hae, Joung Eun Lim, Minyong Kang, et al.. (2021). Genomic mutation profiling using liquid biopsy in Korean patients with prostate cancer: Circulating tumor DNA mutation predicts the development of castration resistance. Investigative and Clinical Urology. 62(2). 224–224. 2 indexed citations
7.
Lee, Hye Won, Woosung Chung, Hae‐Ock Lee, et al.. (2020). Single-cell RNA sequencing reveals the tumor microenvironment and facilitates strategic choices to circumvent treatment failure in a chemorefractory bladder cancer patient. Genome Medicine. 12(1). 47–47. 127 indexed citations
8.
Jeong, Byong Chang, Joung Eun Lim, Hyejeong Kim, et al.. (2020). Bruceantin targets HSP90 to overcome resistance to hormone therapy in castration-resistant prostate cancer. Theranostics. 11(2). 958–973. 38 indexed citations
9.
10.
Jeong, Byong Chang, et al.. (2017). DBC1 promotes castration-resistant prostate cancer by positively regulating DNA binding and stability of AR-V7. Oncogene. 37(10). 1326–1339. 31 indexed citations
11.
12.
Lim, Joung Eun, Hwang Gyun Jeon, Seong Il Seo, et al.. (2016). Curcumin potentiates antitumor activity of cisplatin in bladder cancer cell lines via ROS-mediated activation of ERK1/2. Oncotarget. 7(39). 63870–63886. 96 indexed citations
13.
Song, Wan, Ghee Young Kwon, Jeong Hoon Kim, et al.. (2016). Immunohistochemical staining of ERG and SOX9 as potential biomarkers of docetaxel response in patients with metastatic castration-resistant prostate cancer. Oncotarget. 7(50). 83735–83743. 20 indexed citations
14.
15.
Lee, Hye Won, Kyeung Min Joo, Joung Eun Lim, et al.. (2013). Tpl2 Kinase Impacts Tumor Growth and Metastasis of Clear Cell Renal Cell Carcinoma. Molecular Cancer Research. 11(11). 1375–1386. 17 indexed citations
16.
Park, Bumsoo, Byong Chang Jeong, Yoon‐La Choi, et al.. (2013). Development and characterization of a bladder cancer xenograft model using patient‐derived tumor tissue. Cancer Science. 104(5). 631–638. 32 indexed citations
17.
Yang, Yong-Jin, T. Y. Song, Jungwon Park, et al.. (2013). Menin mediates epigenetic regulation via histone H3 lysine 9 methylation. Cell Death and Disease. 4(4). e583–e583. 43 indexed citations
18.
Kim, Jong Sung, et al.. (2006). Angiogenesis induced by the Transplantation of Autologous Bone Marrow Stem Cells in an Ischemic Canine Model. 3(2). 125–128. 1 indexed citations
19.
Cho, Seung‐Woo, Oju Jeon, Joung Eun Lim, et al.. (2006). Preliminary experience with tissue engineering of a venous vascular patch by using bone marrow–derived cells and a hybrid biodegradable polymer scaffold. Journal of Vascular Surgery. 44(6). 1329–1340. 27 indexed citations
20.
Cho, Seung‐Woo, Joung Eun Lim, Hun Su Chu, et al.. (2005). Enhancement of in vivo endothelialization of tissue‐engineered vascular grafts by granulocyte colony‐stimulating factor. Journal of Biomedical Materials Research Part A. 76A(2). 252–263. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chengzhi Huang Breakdown of academic impact, for papers by Tao Tan Breakdown of academic impact, for papers by Guanghai Dai Breakdown of academic impact, for papers by Yu Wen Breakdown of academic impact, for papers by Quanli Han Breakdown of academic impact, for papers by Chang Yang Breakdown of academic impact, for papers by Xuefeng Liu Breakdown of academic impact, for papers by Zhenfeng Guan Breakdown of academic impact, for papers by Niki A. Ottenhof Breakdown of academic impact, for papers by Hao Peng
Rankless by CCL
2026